Celldex Therapeutics, Price Chart
Celldex Therapeutics, Volume Chart
Celldex Therapeutics, Market Segments
After Hours
+0.00(+0.00%)
| Open | $31.27 |
|---|---|
| Close | $31.27 |
| Low | $31.27 |
| Low Change | 0.00 (0.00%) |
| High | $31.27 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 122.735K |
| Dollar Volume | $3.84M |
Regular Trading Hours
+1.35(+4.51%)
| Open | $29.94 |
|---|---|
| Close | $31.29 |
| Low | $29.94 |
| Low Change | 0.00 (0.00%) |
| High | $31.41 |
| High Change | +1.47 (+4.91%) |
| Range | $1.47 |
| Volume | 454.979K |
| Dollar Volume | $14.24M |
Premarket
+0.00(+0.00%)
| Open | $30.15 |
|---|---|
| Close | $30.15 |
| Low | $30.15 |
| Low Change | 0.00 (0.00%) |
| High | $30.15 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 621 |
| Dollar Volume | $18.72K |
After Hours Yesterday
+0.01(+0.03%)
| Open | $29.96 |
|---|---|
| Close | $29.97 |
| Low | $29.96 |
| Low Change | 0.00 (0.00%) |
| High | $29.97 |
| High Change | +0.01 (+0.03%) |
| Range | $0.01 |
| Volume | 329.89K |
| Dollar Volume | $9.89M |
Regular Trading Hours Yesterday
+0.53(+1.80%)
| Open | $29.41 |
|---|---|
| Close | $29.94 |
| Low | $29.33 |
| Low Change | -0.08 (-0.27%) |
| High | $30.21 |
| High Change | +0.80 (+2.72%) |
| Range | $0.88 |
| Volume | 608.317K |
| Dollar Volume | $18.21M |
Premarket Yesterday
*No Trades in Segment
Celldex Therapeutics, Moving Averages
| 5 Day Moving Average (SMA5) | $29.22 |
|---|---|
| 10 Day Moving Average (SMA10) | $29.63 |
| 20 Day Moving Average (SMA20) | $30.34 |
| 50 Day Moving Average (SMA50) | $31.94 |
| 100 Day Moving Average (SMA100) | $29.69 |
| 200 Day Moving Average (SMA200) | $27.71 |
Celldex Therapeutics, Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Celldex Therapeutics, Stock Splits
There have been 2 stock splits for Celldex Therapeutics, (CLDX). The last reverse stock split occured on February 11, 2019 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Feb 11, 2019 | Reverse | 15:1 |
| Mar 7, 2008 | Reverse | 12:1 |
Celldex Therapeutics, Dividends
There have been no dividends for Celldex Therapeutics, (CLDX).